Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Oct;71(10):7240-5.
doi: 10.1128/JVI.71.10.7240-7245.1997.

Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection

Affiliations

Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection

S F Atabani et al. J Virol. 1997 Oct.

Abstract

Polyclonal sera obtained from African children with acute measles were used to screen a panel of 15-mer overlapping peptides representing the sequence of measles virus (MV) fusion (F) protein. An immunodominant antigenic region from the F protein (p32; amino acids 388 to 402) was found to represent an amino acid sequence within the highly conserved cysteine-rich domain of the F protein of paramyxoviruses. Epitope mapping of this peptide indicated that the complete 15-amino-acid sequence was necessary for high-affinity interaction with anti-MV antibodies. Immunization of two strains of mice with the p32 peptide indicated that it was immunogenic and could induce antipeptide antibodies which cross-reacted with and neutralized MV infectivity in vitro. Moreover, passive transfer of antipeptide antibodies conferred significant protection against fatal rodent-adapted MV-induced encephalitis in susceptible mice. These results indicate that this epitope represents a candidate for inclusion in a future peptide vaccine for measles.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Virus Res. 1994 Apr;32(1):69-84 - PubMed
    1. J Virol. 1995 Dec;69(12):7668-73 - PubMed
    1. J Virol. 1995 Mar;69(3):1420-8 - PubMed
    1. J Virol. 1995 Apr;69(4):2248-56 - PubMed
    1. J Gen Virol. 1997 Jan;78 ( Pt 1):107-11 - PubMed

Publication types

MeSH terms